Evidence map›Paper›PMID 34240266›Full record

ArticleHeart and vessels2022

Fluoroscopy and contrast media use in cryoballoon ablation of atrial fibrillation using a novel imaging system.

Vincenzo Schillaci, Giuseppe Stabile, Alberto Arestia, Gergana Shopova, Alessia Agresta, Sara Poggi, Armando Salita, Carmine Romano, Carlo Maria Giannitti, Andrea Natalizia and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Vincenzo SchillaciClinica Montevergine, Via Mario Malzoni 5, 83013, Mercogliano, AV, Italy.
Giuseppe StabileClinica Montevergine, Via Mario Malzoni 5, 83013, Mercogliano, AV, Italy. gmrstabile@tin.it.ORCID http://orcid.org/0000-0003-4646-0865
Alberto ArestiaClinica Montevergine, Via Mario Malzoni 5, 83013, Mercogliano, AV, Italy.
Gergana ShopovaClinica Montevergine, Via Mario Malzoni 5, 83013, Mercogliano, AV, Italy.
Alessia AgrestaClinica Montevergine, Via Mario Malzoni 5, 83013, Mercogliano, AV, Italy.
Sara PoggiClinica Montevergine, Via Mario Malzoni 5, 83013, Mercogliano, AV, Italy.
Armando SalitaClinica Montevergine, Via Mario Malzoni 5, 83013, Mercogliano, AV, Italy.
Carmine RomanoClinica Montevergine, Via Mario Malzoni 5, 83013, Mercogliano, AV, Italy.
Carlo Maria GiannittiEPD Solution, Milan, Italy.
Andrea NataliziaEPD Solution, Milan, Italy.
Antonio De SimoneCasa di Cura San Michele, Maddaloni, CE, Italy.
Francesco SolimeneClinica Montevergine, Via Mario Malzoni 5, 83013, Mercogliano, AV, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary vein (PV) isolation using cryoballoon (CB) catheter is generally characterized by a high radiation and contrast media exposure. A new dielectric imaging system (KODEX-EPD imaging system) allows pulmonary vein (PV) occlusion assessment without dye use. The purpose of this study was to verify the feasibility of reducing the radiation and dye use during CB ablation in patients with atrial fibrillation (AF) using the new dielectric imaging system. In a retrospective, single center study, we enrolled 34 consecutive patients with paroxysmal AF divided in two groups: 17 patients in Conventional Group underwent the procedure under fluoroscopy guidance before the new system introduction, while 17 patient in KODEX-EPD Group underwent the procedure under fluoroscopy and KODEX-EPD imaging system guidance. There were no differences in any clinical and anatomical characteristics between the two study groups. Overall procedure time was comparable between the two groups (69 [IQR 63-98] min in Conventional Group vs. 65 [IQR 58-74] min in KODEX-EPD Group, p = 0.16), while fluoroscopy time (8 [IQR 5-9] min vs. 11 [IQR 9-12] min, p = 0.014) and dye use (35 [IQR 28-45] ml vs. 70 [IQR 57-83] ml, p < 0.001) were significantly lower in the KODEX-EPD Group. No 30-day complications were observed. At 12-month follow-up 7/37 (19%) patients had an atrial arrhythmias recurrence, without any difference between the two study groups (17.6% vs. 23.5%, p = 0.68). The use of a new dielectric imaging system allowed a significantly reduction in radiation exposure and dye use during CB ablation in patients with AF.

Indexed as

Atrial FibrillationCatheter AblationCryosurgeryContrast MediaFluoroscopyHumansPulmonary VeinsRecurrenceRetrospective StudiesTreatment OutcomeContrast MediaAtrial fibrillationCryoballoon ablationFluoroscopy time

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.